3-187236319-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_139125.4(MASP1):​c.1552G>A​(p.Val518Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000642 in 1,614,254 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00039 ( 4 hom. )

Consequence

MASP1
NM_139125.4 missense

Scores

3
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.37

Publications

2 publications found
Variant links:
Genes affected
MASP1 (HGNC:6901): (MBL associated serine protease 1) This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
MASP1 Gene-Disease associations (from GenCC):
  • 3MC syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • 3MC syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009975851).
BP6
Variant 3-187236319-C-T is Benign according to our data. Variant chr3-187236319-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 702180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00307 (468/152362) while in subpopulation AFR AF = 0.0103 (428/41586). AF 95% confidence interval is 0.00949. There are 0 homozygotes in GnomAd4. There are 207 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139125.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP1
NM_139125.4
MANE Select
c.1552G>Ap.Val518Ile
missense
Exon 11 of 11NP_624302.1
MASP1
NM_001879.6
MANE Plus Clinical
c.1303+5162G>A
intron
N/ANP_001870.3
MASP1
NR_033519.2
n.1425G>A
non_coding_transcript_exon
Exon 10 of 10

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP1
ENST00000296280.11
TSL:1 MANE Select
c.1552G>Ap.Val518Ile
missense
Exon 11 of 11ENSP00000296280.7
MASP1
ENST00000392472.6
TSL:1
c.1213G>Ap.Val405Ile
missense
Exon 10 of 10ENSP00000376264.2
MASP1
ENST00000337774.10
TSL:1 MANE Plus Clinical
c.1303+5162G>A
intron
N/AENSP00000336792.5

Frequencies

GnomAD3 genomes
AF:
0.00308
AC:
469
AN:
152244
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000875
AC:
220
AN:
251292
AF XY:
0.000670
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.000607
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000389
AC:
569
AN:
1461892
Hom.:
4
Cov.:
82
AF XY:
0.000378
AC XY:
275
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0103
AC:
345
AN:
33480
American (AMR)
AF:
0.000671
AC:
30
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000614
AC:
53
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000845
AC:
94
AN:
1112012
Other (OTH)
AF:
0.000778
AC:
47
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00307
AC:
468
AN:
152362
Hom.:
0
Cov.:
33
AF XY:
0.00278
AC XY:
207
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.0103
AC:
428
AN:
41586
American (AMR)
AF:
0.00202
AC:
31
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68034
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
1
Bravo
AF:
0.00370
ESP6500AA
AF:
0.0104
AC:
46
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00118
AC:
143
Asia WGS
AF:
0.000866
AC:
4
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
3MC syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
19
DANN
Benign
0.90
Eigen
Benign
-0.14
Eigen_PC
Benign
0.017
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.010
T
MetaSVM
Uncertain
0.18
D
PhyloP100
2.4
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.030
N
REVEL
Uncertain
0.35
Sift
Benign
0.83
T
Sift4G
Benign
0.61
T
Polyphen
0.046
B
Vest4
0.20
MVP
0.64
MPC
0.14
ClinPred
0.026
T
GERP RS
5.1
gMVP
0.27
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73068950; hg19: chr3-186954107; COSMIC: COSV99962716; API